What is the Fiscal Year for InMed Pharmaceuticals?
Date: November 13, 2026
InMed Pharmaceuticals's current fiscal year starts on July 1, 2026, and ends on June 30, 2027. Their current quarter is Q2, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
July 1, 2026
Fiscal Year End
June 30, 2027
Current Quarter
Q2
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jul 1, 2026 – Sep 30, 2026
Q2
Oct 1, 2026 – Dec 31, 2026
Q3
Jan 1, 2027 – Mar 31, 2027
Q4
Apr 1, 2027 – Jun 30, 2027
Company Information
Headquarters
Vancouver, British Columbia, Canada
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
INM
Website
https://inmedpharma.comDescription
InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a global leader in the manufacturing, development and commercialization of products based on rare cannabinoids and their proprietary, small molecule drug analogs. For more information, visit www.inmedpharma.com. Nasdaq: INM
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like InMed Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.